$AKYA
Akoya Biosciences, Inc. Stock $akya

$akya Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000155837024002380 Filed on March 05, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$18.35M	$26.49M	$96.63M
YoY Change	-14.29%	24.83%	29.09%
Cost Of Revenue	$9.971M	$9.867M	$40.33M
YoY Change	9.37%	7.57%	28.15%
Gross Profit	$8.379M	$16.62M	$56.31M
YoY Change	-31.84%	37.97%	29.76%
Gross Profit Margin	45.66%	62.75%	58.27%
Selling, General & Admin	$19.86M	$18.90M	$82.38M
YoY Change	-8.71%	-9.79%	3.42%
% of Gross Profit	237.06%	113.71%	146.31%
Research & Development	$5.554M	$4.670M	$21.89M
YoY Change	-3.79%	-27.41%	-5.7%
% of Gross Profit	66.28%	28.1%	38.88%
Depreciation & Amortization	$2.051M	$2.106M	$8.890M
YoY Change	-3.3%	10.78%	24.35%
% of Gross Profit	24.48%	12.67%	15.79%
Operating Expenses	$29.96M	$26.06M	$114.0M
YoY Change	0.79%	-12.07%	4.09%
Operating Profit	-$21.59M	-$9.439M	-$57.67M
YoY Change	23.8%	-46.34%	-12.76%
Interest Expense	-$2.612M	-$1.380M	-$8.761M
YoY Change	27.17%	28.97%	92.38%
% of Operating Profit
Other Income/Expense, Net	-$161.0K	-$5.000K	-$343.0K
YoY Change	235.42%	-97.92%	-45.98%
Pretax Income	-$23.42M	-$10.82M	-$63.28M
YoY Change	24.76%	-42.73%	-10.26%
Income Tax	$63.00K	-$22.00K	$40.00K
% Of Pretax Income
Net Earnings	-$23.48M	-$10.80M	-$63.32M
YoY Change	24.9%	-42.77%	-10.36%
Net Earnings / Revenue	-127.98%	-40.78%	-65.53%
Basic Earnings Per Share	-$0.48		-$1.43
Diluted Earnings Per Share	-$0.48	-$0.22	-$1.43
COMMON SHARES
Basic Shares Outstanding	49.14M	49.08M	44.43M
Diluted Shares Outstanding	49.19M		44.43M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$61.58M	$83.13M	$83.13M
YoY Change	2.2%	2.35%	2.35%
Cash & Equivalents	$13.04M	$83.13M	$83.13M
Short-Term Investments	$48.54M
Other Short-Term Assets	$3.793M	$3.794M	$3.794M
YoY Change	-4.63%	-43.91%	-43.91%
Inventory	$22.99M	$17.88M	$17.88M
Prepaid Expenses
Receivables	$13.47M	$16.99M	$16.99M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$101.8M	$121.8M	$121.8M
YoY Change	11.08%	8.55%	8.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.964M	$10.73M	$21.55M
YoY Change	-14.01%	5.46%	-12.16%
Goodwill	$18.26M	$18.26M
YoY Change	0.0%	0.0%
Intangibles	$16.70M	$17.41M
YoY Change	-14.35%	-13.15%
Long-Term Investments
YoY Change
Other Assets	$654.0K	$657.0K	$1.356M
YoY Change	-5.49%	-4.51%	36.83%
Total Long-Term Assets	$52.92M	$58.58M	$58.58M
YoY Change	-15.49%	-8.23%	-8.23%
TOTAL ASSETS
Total Short-Term Assets	$101.8M	$121.8M	$121.8M
Total Long-Term Assets	$52.92M	$58.58M	$58.58M
Total Assets	$154.8M	$180.4M	$180.4M
YoY Change	0.29%	2.46%	2.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.75M	$11.78M	$11.78M
YoY Change	23.77%	10.8%	10.8%
Accrued Expenses	$12.46M	$13.43M	$13.11M
YoY Change	-12.85%	-18.68%	-26.44%
Deferred Revenue	$6.612M	$6.688M
YoY Change	-0.68%	6.51%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$718.0K	$767.0K	$767.0K
YoY Change	18.09%	23.71%	23.71%
Total Short-Term Liabilities	$33.19M	$35.35M	$35.35M
YoY Change	-0.09%	-4.61%	-4.61%
LONG-TERM LIABILITIES
Long-Term Debt	$75.47M	$75.25M	$76.02M
YoY Change	18.93%	18.93%	18.87%
Other Long-Term Liabilities	$12.73M	$15.20M	$15.20M
YoY Change	-14.38%	-7.09%	-7.09%
Total Long-Term Liabilities	$75.47M	$75.25M	$91.22M
YoY Change	18.93%	18.93%	13.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$33.19M	$35.35M	$35.35M
Total Long-Term Liabilities	$75.47M	$75.25M	$91.22M
Total Liabilities	$122.0M	$126.6M	$126.6M
YoY Change	8.78%	7.79%	7.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$253.6M	-$230.1M
YoY Change	36.65%	37.98%
Common Stock	$2.000K	$2.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$32.72M	$53.77M	$53.77M
YoY Change
Total Liabilities & Shareholders Equity	$154.8M	$180.4M	$180.4M
YoY Change	0.29%	2.46%	2.46%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$23.48M	-$10.80M	-$63.32M
YoY Change	24.9%	-42.77%	-10.36%
Depreciation, Depletion And Amortization	$2.051M	$2.106M	$8.890M
YoY Change	-3.3%	10.78%	24.35%
Cash From Operating Activities	-$20.82M	-$5.584M	-$50.90M
YoY Change	5.4%	-44.2%	-4.85%
INVESTING ACTIVITIES
Capital Expenditures	$810.0K	$594.0K	$3.653M
YoY Change	0.75%	-31.65%	-50.37%
Acquisitions
YoY Change
Other Investing Activities	-$48.01M	$0.00	$7.000M
YoY Change	-785.81%	-100.0%	-204.18%
Cash From Investing Activities	-$48.82M	-$594.0K	$3.347M
YoY Change	-887.88%	-102.68%	-123.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$47.97M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-444.0K	11.08M	56.84M
YoY Change	5.97%	7.86%	97.88%
NET CHANGE
Cash From Operating Activities	-20.82M	-5.584M	-50.90M
Cash From Investing Activities	-48.82M	-594.0K	3.347M
Cash From Financing Activities	-444.0K	11.08M	56.84M
Net Change In Cash	-70.09M	4.899M	9.292M
YoY Change	401.29%	-78.12%	-123.92%
FREE CASH FLOW
Cash From Operating Activities	-$20.82M	-$5.584M	-$50.90M
Capital Expenditures	$810.0K	$594.0K	$3.653M
Free Cash Flow	-$21.63M	-$6.178M	-$54.55M
YoY Change	5.21%	-43.2%	-10.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.43
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44434570
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37746915
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#OperatingExpenses
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44434570
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37746915
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.43
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
CY2023	akya	Extended Service Based Warranty Terms ExtendedServiceBasedWarrantyTerms	P1Y
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38288188
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49117738
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001711933
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0250
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0386
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38288188
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	676000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49117738
CY2023Q4	us-gaap	Lease Practical Expedient Lessor Single Lease Component LeasePracticalExpedientLessorSingleLeaseComponent	true
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40344
CY2023	dei	Entity Registrant Name EntityRegistrantName	Akoya Biosciences, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5586242
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Campus Drive
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	6th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Marlborough
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01752
CY2023	dei	City Area Code CityAreaCode	855
CY2023	dei	Local Phone Number LocalPhoneNumber	896-8401
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.00001 per share
CY2023	dei	Trading Symbol TradingSymbol	AKYA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	186400000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49140731
CY2023	dei	Auditor Firm AuditorFirmId	49
CY2023	dei	Auditor Name AuditorName	RSM US LLP
CY2023	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83125000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74229000
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	6989000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16994000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9729000
CY2023Q4	us-gaap	Inventory Net InventoryNet	17877000
CY2022Q4	us-gaap	Inventory Net InventoryNet	14486000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3794000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6764000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	121790000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	112197000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10729000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10174000
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	699000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	303000
CY2023Q4	akya	Demo Inventory Net DemoInventoryNet	893000
CY2022Q4	akya	Demo Inventory Net DemoInventoryNet	2084000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17412000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20048000
CY2023Q4	us-gaap	Goodwill Goodwill	18262000
CY2022Q4	us-gaap	Goodwill Goodwill	18262000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8365000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10785000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1562000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1490000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	657000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	688000
CY2023Q4	us-gaap	Assets Assets	180369000
CY2022Q4	us-gaap	Assets Assets	176031000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11776000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10628000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13433000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16519000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2681000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3009000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	767000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	620000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6688000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6279000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	35345000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37055000
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3193000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2114000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75254000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	63277000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	87000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6238000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8203000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	766000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	675000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5765000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	6039000
CY2023Q4	us-gaap	Liabilities Liabilities	126599000
CY2022Q4	us-gaap	Liabilities Liabilities	117450000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49117738
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38288188
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	283839000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	225333000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-230071000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-166748000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	53770000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	58581000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	180369000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	176031000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96633000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74859000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	40328000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	31469000
CY2023	us-gaap	Gross Profit GrossProfit	56305000
CY2022	us-gaap	Gross Profit GrossProfit	43390000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	82381000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	79653000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21889000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23211000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1636000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-102000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8067000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6734000
CY2023	us-gaap	Operating Expenses OperatingExpenses	113973000
CY2022	us-gaap	Operating Expenses OperatingExpenses	109496000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-57668000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-66106000
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-8761000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-4554000
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	3489000
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	777000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-343000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-635000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63283000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-70518000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	123000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-63323000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70641000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.43
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44434570
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37746915
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-63323000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70641000
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	6000
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-6000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-63317000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-70647000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	121351000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	447000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70641000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7430000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	58581000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	346000
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	94000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	47817000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-63323000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10437000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	53770000
CY2023	us-gaap	Profit Loss ProfitLoss	-63323000
CY2022	us-gaap	Profit Loss ProfitLoss	-70641000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8890000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7149000
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	727000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	608000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	10437000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7430000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-51000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	35000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1636000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-102000
CY2023	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	5000
CY2022	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	221000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-82000
CY2023	akya	Operating Lease Adjustment OperatingLeaseAdjustment	2420000
CY2022	akya	Operating Lease Adjustment OperatingLeaseAdjustment	2011000
CY2023	akya	Change In Inventory Reserve Adjustment ChangeInInventoryReserveAdjustment	2848000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7265000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	285000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2257000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-798000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6332000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5374000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1148000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1193000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3481000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2826000
CY2023	akya	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-2293000
CY2022	akya	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1584000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1488000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2579000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50899000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-53496000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3653000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7360000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	55000
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	40774000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	7000000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	34000000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3347000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14079000
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	11250000
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	31250000
CY2022	akya	Refunds From Payments Of Accrued Termination Fees RefundsFromPaymentsOfAccruedTerminationFees	-779000
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	33000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	240000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47967000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	346000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	447000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	94000
CY2023	akya	Refunds From Payments Of Deferred Offering Costs RefundsFromPaymentsOfDeferredOfferingCosts	-207000
CY2022	akya	Refunds From Payments Of Deferred Offering Costs RefundsFromPaymentsOfDeferredOfferingCosts	-124000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	676000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	621000
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1709000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1207000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	56844000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28726000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9292000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-38849000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74532000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	113381000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83824000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74532000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	7650000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	3477000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	56000
CY2023	akya	Right Of Use Asset Obtained In Exchange For Lease Liabilities RightOfUseAssetObtainedInExchangeForLeaseLiabilities	914000
CY2023	akya	Unpaid Stock Offering Costs UnpaidStockOfferingCosts	150000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	697000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	229000
CY2023	akya	Number Of Geographic Regions For Sales NumberOfGeographicRegionsForSales	3
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83125000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-230071000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50899000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;">Use of estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company utilizes certain estimates in the determination of the fair value of its stock options, the useful lives of property and equipment, revenue recognition, determining the fair value of intangible assets, marketable securities, accrued expenses, income tax accounting, the value of purchase consideration paid and identifiable assets acquired and assumed in acquisitions, contingent consideration, goodwill and intangible asset impairment review, and other contingencies. The Company bases its estimates on historical experience and other market-specific or other relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from such estimates.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;padding-left:36pt;text-indent:-36pt;margin:0pt 0pt 12pt 0pt;">Concentrations of credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents are financial instruments that potentially subject the Company to concentrations of credit risk. The Company maintains its cash deposits, which generally exceed federally insured limits, with large financial institutions and, accordingly, the Company believes their cash and cash equivalents are subject to minimal credit risk.</p>
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16994000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	45000
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	0
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	45000
CY2023	akya	Standard Service Based Warranty Terms StandardServiceBasedWarrantyTerms	P1Y
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96633000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74859000
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1276000
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2023	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
CY2023Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	746000
CY2022Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	1372000
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2334000
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	4638000
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	331000
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	326000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P4Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000
CY2023Q4	akya	Cash Cash Equivalents And Marketable Securities Cost Basis CashCashEquivalentsAndMarketableSecuritiesCostBasis	76844000
CY2023Q4	akya	Cash Cash Equivalents And Marketable Securities Fair Value Disclosure CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure	76844000
CY2022Q4	akya	Cash Cash Equivalents And Marketable Securities Cost Basis CashCashEquivalentsAndMarketableSecuritiesCostBasis	7251000
CY2022Q4	akya	Cash Cash Equivalents And Marketable Securities Gross Unrealized Losses CashCashEquivalentsAndMarketableSecuritiesGrossUnrealizedLosses	6000
CY2022Q4	akya	Cash Cash Equivalents And Marketable Securities Fair Value Disclosure CashCashEquivalentsAndMarketableSecuritiesFairValueDisclosure	7245000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2853000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2853000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2822000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1956000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1761000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5167000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17412000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20392000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16499000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9663000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6325000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10729000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10174000
CY2022	akya	Demo Inventory Estimated Useful Life DemoInventoryEstimatedUsefulLife	P3Y
CY2023	akya	Demo Inventory Estimated Useful Life DemoInventoryEstimatedUsefulLife	P3Y
CY2023Q4	akya	Demo Inventory Gross DemoInventoryGross	4284000
CY2022Q4	akya	Demo Inventory Gross DemoInventoryGross	4453000
CY2023Q4	akya	Accumulated Depreciation Depletion And Amortization Demo Inventory AccumulatedDepreciationDepletionAndAmortizationDemoInventory	3391000
CY2022Q4	akya	Accumulated Depreciation Depletion And Amortization Demo Inventory AccumulatedDepreciationDepletionAndAmortizationDemoInventory	2369000
CY2023Q4	akya	Demo Inventory Net DemoInventoryNet	893000
CY2022Q4	akya	Demo Inventory Net DemoInventoryNet	2084000
CY2023	akya	Depreciation Demo Inventory DepreciationDemoInventory	1286000
CY2022	akya	Depreciation Demo Inventory DepreciationDemoInventory	1223000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29990000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12578000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17412000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29244000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9196000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20048000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7074000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8288000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1911000
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1709000
CY2023Q4	akya	Accrued Inventory Purchases AccruedInventoryPurchases	609000
CY2022Q4	akya	Accrued Inventory Purchases AccruedInventoryPurchases	488000
CY2023Q4	akya	Customer Deposit Liability Current CustomerDepositLiabilityCurrent	1096000
CY2022Q4	akya	Customer Deposit Liability Current CustomerDepositLiabilityCurrent	3652000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2743000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2382000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13433000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16519000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	448000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	565000
CY2023Q4	akya	Debt Instrument Accretion Of Fee DebtInstrumentAccretionOfFee	702000
CY2022Q4	akya	Debt Instrument Accretion Of Fee DebtInstrumentAccretionOfFee	92000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	75254000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	63277000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023	akya	Common Stock Voting Rights Per Share CommonStockVotingRightsPerShare	1
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49117738
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38288188
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	8912043
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7834432
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-63520000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-70736000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	237000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	218000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63283000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-70518000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	90000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	84000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	91000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	88000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-20000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	30000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-30000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	32000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-27000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-51000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	35000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	123000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0154
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0354
CY2023	akya	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.0134
CY2022	akya	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.0062
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2131
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2428
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.0250
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.0386
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0002
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.0007
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.0021
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0006
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0017
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	31442000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26854000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	7985000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5122000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	934000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1033000
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	817000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	528000
CY2023Q4	akya	Deferred Tax Assets Deferred Expense Interest DeferredTaxAssetsDeferredExpenseInterest	2788000
CY2022Q4	akya	Deferred Tax Assets Deferred Expense Interest DeferredTaxAssetsDeferredExpenseInterest	1653000
CY2023Q4	akya	Deferred Tax Assets Stock Transactions DeferredTaxAssetsStockTransactions	2272000
CY2022Q4	akya	Deferred Tax Assets Stock Transactions DeferredTaxAssetsStockTransactions	1522000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4061000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1164000
CY2023Q4	akya	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	2107000
CY2022Q4	akya	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	2776000
CY2023Q4	akya	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	312000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	778000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	431000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	53496000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41083000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	51359000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37873000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2137000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3210000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	261000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	160000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	329000
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1976000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2670000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	50000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	39000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	37000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	126870000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	107446000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	2567000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	124303000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	74939000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	67173000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4226000
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	3228000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7454000
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1687000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9141000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9141000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-63323000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70641000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44434570
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37746915
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.43
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	562000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10354000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1435000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7101027
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6590725
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	96633000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74859000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	142000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	60000
CY2023	us-gaap	Lease Cost LeaseCost	4241000
CY2022	us-gaap	Lease Cost LeaseCost	3921000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2777000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2839000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2636000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1104000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	436000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8919000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	798000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	444000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	239000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	239000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	60000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	1780000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	247000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1533000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0785
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0785
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0958
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0673
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	3130000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	3009000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	142000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	60000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	621000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	2056000
CY2023Q4	akya	Accrued Liabilities Restructuring Charges AccruedLiabilitiesRestructuringCharges	15000
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
akya-20231231_cal.xml	Edgar Link	unprocessable
0001558370-24-002380-index-headers.html	Edgar Link	pending
0001558370-24-002380-index.html	Edgar Link	pending
0001558370-24-002380.txt	Edgar Link	pending
0001558370-24-002380-xbrl.zip	Edgar Link	pending
akya-20231231.xsd	Edgar Link	pending
akya-20231231x10k.htm	Edgar Link	pending
akya-20231231x10k002.jpg	Edgar Link	pending
akya-20231231x10k003.jpg	Edgar Link	pending
akya-20231231x10k004.jpg	Edgar Link	pending
akya-20231231x10k005.jpg	Edgar Link	pending
akya-20231231x10k006.jpg	Edgar Link	pending
akya-20231231x10k007.jpg	Edgar Link	pending
akya-20231231x10k008.jpg	Edgar Link	pending
akya-20231231x10k009.jpg	Edgar Link	pending
akya-20231231x10k010.jpg	Edgar Link	pending
akya-20231231x10k011.jpg	Edgar Link	pending
akya-20231231x10k013.jpg	Edgar Link	pending
akya-20231231x10k014.jpg	Edgar Link	pending
akya-20231231xex23.htm	Edgar Link	pending
akya-20231231xex31d1.htm	Edgar Link	pending
akya-20231231xex31d2.htm	Edgar Link	pending
akya-20231231xex32.htm	Edgar Link	pending
akya-20231231xex97d1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
akya-20231231_def.xml	Edgar Link	unprocessable
akya-20231231_lab.xml	Edgar Link	unprocessable
akya-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
akya-20231231x10k_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AKYA
Akoya Biosciences, Inc. Stock $akya

2024 Q1 Form 10-K Financial Statement

#000155837024002380 Filed on March 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKYA Akoya Biosciences, Inc. Stock $akya

2024 Q1 Form 10-K Financial Statement

#000155837024002380 Filed on March 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKYA
Akoya Biosciences, Inc. Stock $akya